GSA Capital Partners LLP Buys Shares of 63,018 Wright Medical Group NV (WMGI)

GSA Capital Partners LLP bought a new position in Wright Medical Group NV (NASDAQ:WMGI) in the third quarter, HoldingsChannel reports. The firm bought 63,018 shares of the medical device company’s stock, valued at approximately $1,829,000.

Several other hedge funds also recently bought and sold shares of WMGI. Principal Financial Group Inc. raised its holdings in Wright Medical Group by 7.0% in the 1st quarter. Principal Financial Group Inc. now owns 92,781 shares of the medical device company’s stock worth $1,841,000 after purchasing an additional 6,084 shares during the period. Amalgamated Bank raised its holdings in Wright Medical Group by 14.9% in the 2nd quarter. Amalgamated Bank now owns 16,232 shares of the medical device company’s stock worth $421,000 after purchasing an additional 2,102 shares during the period. Aperio Group LLC acquired a new position in shares of Wright Medical Group during the second quarter valued at approximately $364,000. Los Angeles Capital Management & Equity Research Inc. acquired a new position in shares of Wright Medical Group during the second quarter valued at approximately $362,000. Finally, Sivik Global Healthcare LLC acquired a new position in shares of Wright Medical Group during the second quarter valued at approximately $2,204,000.

In other news, Director Elizabeth H. Weatherman sold 15,949 shares of the firm’s stock in a transaction on Monday, November 19th. The stock was sold at an average price of $28.63, for a total transaction of $456,619.87. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Peter Cooke sold 13,478 shares of the firm’s stock in a transaction on Friday, November 2nd. The stock was sold at an average price of $28.03, for a total value of $377,788.34. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 67,466 shares of company stock valued at $1,962,392. Company insiders own 4.00% of the company’s stock.

A number of equities analysts have commented on the company. Robert W. Baird increased their target price on Wright Medical Group from $28.00 to $32.00 and gave the company an “outperform” rating in a report on Thursday, August 9th. Needham & Company LLC increased their target price on Wright Medical Group from $30.00 to $35.00 and gave the company a “buy” rating in a report on Thursday, October 25th. Piper Jaffray Companies increased their target price on Wright Medical Group to $35.00 and gave the company an “overweight” rating in a report on Thursday, November 8th. BidaskClub cut Wright Medical Group from a “buy” rating to a “hold” rating in a report on Wednesday, November 28th. Finally, BMO Capital Markets raised Wright Medical Group from a “market perform” rating to an “outperform” rating and increased their target price for the company from $28.00 to $31.00 in a report on Wednesday, August 29th. Three research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. The company has an average rating of “Buy” and a consensus target price of $32.62.

WMGI opened at $28.04 on Tuesday. Wright Medical Group NV has a 52 week low of $19.01 and a 52 week high of $30.75. The firm has a market cap of $3.50 billion, a PE ratio of -127.45 and a beta of 1.15. The company has a quick ratio of 1.07, a current ratio of 1.24 and a debt-to-equity ratio of 0.61.

Wright Medical Group (NASDAQ:WMGI) last released its quarterly earnings results on Wednesday, November 7th. The medical device company reported ($0.09) EPS for the quarter, topping the consensus estimate of ($0.15) by $0.06. Wright Medical Group had a negative return on equity of 0.60% and a negative net margin of 13.07%. The business had revenue of $194.11 million during the quarter, compared to analyst estimates of $186.09 million. During the same period last year, the business posted ($0.16) earnings per share. The company’s quarterly revenue was up 13.8% on a year-over-year basis. Equities research analysts predict that Wright Medical Group NV will post -0.07 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION WARNING: This story was originally posted by Community Financial News and is owned by of Community Financial News. If you are viewing this story on another domain, it was stolen and republished in violation of US and international trademark and copyright law. The original version of this story can be accessed at https://www.com-unik.info/2018/12/04/gsa-capital-partners-llp-buys-shares-of-63018-wright-medical-group-nv-wmgi.html.

About Wright Medical Group

Wright Medical Group N.V., a medical device company, designs, manufactures, markets, and sells extremities and biologics products. The company offers joint implants and bone fixation devices for the shoulder, elbow, wrist, hand, foot, and ankle; and biologics products that are used for supporting the treatment of damaged or diseased bones, tendons, and soft tissues, as well as to stimulate bone growth.

Featured Article: What is a Stop Order?

Want to see what other hedge funds are holding WMGI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Wright Medical Group NV (NASDAQ:WMGI).

Institutional Ownership by Quarter for Wright Medical Group (NASDAQ:WMGI)

Receive News & Ratings for Wright Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Wright Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit